Here I am, back from a three-week hiatus. You may recall from my last newsletter prior to that hiatus I urged all my long term investors to stay in cash while possibly allocating some portion of their portfolio to biotechs.

So far, this seems to have been pretty good advice. The stock market had one of its worst months of August ever. Of course, over the past week or so, the market has been rallying so many of the talking heads are all a twitter about the arrival of a new bull market.

This continues to seem pretty much like a sucker's game to me. To understand why, try this little exercise. Go to Yahoo finance and pull up the three-month chart for SPY -- the exchange traded fund the Standard & Poor's 500 index. If you got suckered into buying the bottom hit on June 6, you would've had a very healthy gain by June 17. However, by July 6, you would've been deep in the red.

By the same token, if you bought the bottom on July 2, you would have been in great shape right up till August 9 – and then been gutted like a pig.

Okay, so let's say you were smart enough to buy the dip on September 3 at $105 a share. Now you're up already five bucks and you think you're a genius. But what makes you think that after another run-up, the market is just going to run right back down?

Please keep in mind, I'm usually not this cynical about the market trend. Usually, it's pretty damn clear whether the economy is, as Bob Dylan might say, "busy being born" or "busy dying." But there is so much uncertainty right now in the economy, that the only really sensible thing for the market to do is to trade in the sideways pattern until things resolve themselves.

I myself am not particularly in the double dip recession camp. When I see is what we've had over much of the last decade – slow GDP growth well below our potential output. That will in turn mean persistent high employment and stagnant wage growth. How you get a bull market out of that – and the Dow at 20,000 – I really don't know.

I wish I had better news, but we have to trade or invest the hand that we are dealt – or sit patiently on the sidelines in cash.

For traders, I myself am growing increasingly disenchanted with a long short strategy unless you have great skills at risk management and rapid trading.

What happens in a sideways market with a hedge portfolio is that your shorts get stopped out when the market runs up, and your longs get stopped out when the market runs down. All you wind up with is modest losses over a lot of stocks that add up to a big loss – plus a lot of transactions costs.

So if you didn't make any money over the last couple months in your short-term trading strategy, I'd strongly advise you to hang your cleats and mouse up for a while until this market is easier to make money on.

As for the long-term investor, I continue to recommend cash for now. I also continue to hold about 20 to 25% my own portfolio and small-cap biotechs. And by the way, I will send you a Special Report on my biotech picks this coming Wednesday based on a conversation I had one of the top biotech analyst in the world – Andrew Vaino of Roth capital. (I did a segment last Friday on CNBC that talked about a few of the stocks Andrew is following, but a lot of the best stocks I could really talk about on TV because their small caps.)

Last take: my new book Seeds of Destruction with former Bush White House chief economic advisor Glenn Hubbard is now available on Amazon and at Barnes & Noble and, as they say, other fine bookstores everywhere. Please buy this book right away, not because I need your royalty money, but because unless the boneheads in Washington change their policy tunes pretty damn quick, we are going to keep heading right down the tubes.

Navarro on TheStreet.com
Click here to review my videos on TheStreet.com.
———-

Professor Navarro’s articles have appeared in a wide range of publications, from Business Week, the Los Angeles Times, New York Times and Wall Street Journal to the Harvard Business Review, the MIT Sloan Management Review, and the Journal of Business. His free weekly newsletter is published at www.PeterNavarro.com.

© 2010 Copyright Peter Navarro - All Rights Reserved
Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.